[Luces y sombras de la Guía Europea esc-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica.]
Related Experiment Video
Updated: Jul 11, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Enrique Martín-Rioboó1, Carlos Brotons-Cuixart2, Antonio Ruiz García3
1Médico de Familia; Unidad de Gestión Clínica Poniente; Distrito Universitario Córdoba-Guadalquivir; Departamento de Medicina; Universidad de Córdoba. / IMIBIC; Hospital Reina Sofía. Córdoba. España.
Insights
The 2021 European Cardiovascular Guidelines offer improved vascular risk (VR) assessment using SCORE2 and SCORE2-OP models. However, complexity in implementation may hinder primary care, necessitating practical recommendations for effective risk factor management.
Area of Science:
- Cardiology
- Primary Care Medicine
- Public Health
Context:
- General practitioners manage numerous patients with high vascular risk (VR).
- The 2021 European Guidelines for Cardiovascular Disease Prevention introduce new risk classification and intervention strategies for vascular risk factors (RF).
- These guidelines aim to foster shared decision-making between healthcare professionals and patients.
Purpose:
- To critically analyze the 2021 European Cardiovascular Guidelines for Primary Care implementation.
- To identify both positive advancements and potential challenges within the new guidelines.
- To propose practical solutions for simplifying guideline adoption in primary care settings.
Summary:
- The SCORE2 and SCORE2-OP models provide more accurate cardiovascular risk estimation based on current data.
- New guidelines propose age-specific risk thresholds and subgroup classifications.
- Potential drawbacks include increased complexity and possible delays in achieving therapeutic goals for high-risk patients.
Impact:
- Facilitating the practical implementation of updated cardiovascular disease prevention guidelines in primary care.
- Improving the management of vascular risk factors in a primary care setting.
- Enhancing shared decision-making for patients at high vascular risk.
Abstract:
General practitioners see in their consultation a a significant number of patients at high vascular risk (VR). The European Guidelines for Cardiovascular Disease Prevention (2021) recommend a new risk classification and intervention strategies on on vascular risk factors (RF), with the aim of providing a shared decision-making recommendations between professionals and patients. In this document we present a critical analysis of these guidelines, offering possible solutions that can be implemented in Primary Care. It should be noted that there are positive aspects (lights) such as that the SCORE2 (from forty to sixty-nine years) and SCORE2-OP models (from seventy to eighty-nine years) are based on more current cohorts and measure cardiovascular risk in a more accurately manner. In addition, it is proposed to differentiate different risk thresholds according to age-groups. For sake of practicality, cardiovascular risk can be estimated using different websites with the new computer models. However, among the negative aspects (shadows), it seems to be add complexity implementing nine subgroups of subjects according to their age or level of risk, with a defined thresholds that could cause a substantial increase in the potential number of subjects susceptible to treatment without a clear evidence that supports it. In addition, two-step RF interventions could delay achievement of therapeutic goals, especially in very high-risk patients, diabetics, or patients with cardiovascular disease. Given these limitations, in this document we propose practical recommendations in order to simplify and facilitate the implementation of the guideline in primary care.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Cardiovascular Drugs: Classification based on Therapeutic Indications
Atherosclerosis III: Management
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

